demonstrated that TMPRSS4 promotes prostate cancer cells to resist anoikis, thereby improving the survival of circulating tumor cells and promoting early metastasis, and demonstrated that TMPRSS4 promotes CSC characteristics of prostate cancer by upregulating SLUG and TWIST1-induced stem cell factor SOX2 (17). The gene discussed is SOX2; the disease is prostate cancer.